New potential anti-tumour compounds
23-Dec-2010
- China
The researchers found that 13 compounds were active against tumours and nine were more active than cytarabine, a compound used to treat acute myeloid leukemia and non-Hodgkin lymphoma. They also carried out toxicity studies and found that the compounds did not damage the immunologic function of mice.
Original publication: L Liu, L Wei, Y Yang, M Zhao, X Zhang, M Zheng, Y Wang and S Peng, MedChemComm, 2011.
Most read news
Organizations
Royal Society of Chemistry
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Last viewed contents
Rossel-Display - Birstein-Lichenroth, Germany
Go to page
Rottendorf Pharma GmbH - Ennigerloh, Germany
Go to page
Codexis Opens Singapore Laboratory
Go to page
DeCODE genetics Announces Full-year 2004 Financial Results
Go to page
Karolinska Institutet opens office in Singapore
Go to page
Genmab Announces Phase II Study of Daratumumab in Non-Hodgkin’s Lymphomas
Go to page
Fibril
Go to page
Joseph_Toynbee
Go to page
Biotechnology
Go to page
Equateq Facility Certified for GMP Pharma Production in Scotland
Go to page
Ablynx appoints Dr. Andreas Menrad as Chief Scientific Officer
Go to page
German_Sims_Woodhead
Go to page